Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Canadian Solar's e-STORAGE to Deliver 2 GWh of Energy Storage Systems in the UK for Copenhagen Infrastructure Partners
-
FDA Accepts Agios’ Supplemental New Drug Application for PYRUKYND® (mitapivat) in Adult Patients with Non-Transfusion-Dependent and Transfusion-Dependent Alpha- or Beta-Thalassemia
-
I-Mab Announces Open Market Purchases of Company American Depositary Shares by Board Member
-
Boston Scientific Announces Agreement to Acquire Bolt Medical, Inc.
-
MediPharm Labs Enters Landmark Commercial Agreement with Laboratório Teuto in Brazil
-
Kamada Affirms 2024 Financial Guidance and Announces Expected Continued Double-Digit Profitable Growth for 2025
-
Blue Sky Announces Mailing and Filing of Circular for Special Meeting of Shareholders to Approve the Earn-In Agreement with COAM
-
Dianthus Therapeutics to Webcast Presentation at the 43rd Annual J.P. Morgan Healthcare Conference
-
Alesta Therapeutics Raises €65 Million Series A Financing to Advance Oral Small Molecules for Rare Diseases
-
BioStem Technologies Launches Clinical Trial to Demonstrate the Therapeutic Benefits of its BioREtain® Technology in Treating Diabetic Foot Ulcers Using Vendaje®
-
Mantle Ridge Issues Shareholder Letter Outlining the Path Forward for Air Products and Chemicals, Inc.
-
Miami Beach and Blue Zones Join Forces to Transform Health of City
-
Best of 2024 Self-Service and Kiosk Awards
-
BIO-TECHNE TO PRESENT AT PHACILITATE ADVANCED THERAPIES WEEK 2025
-
Tonix Pharmaceuticals Further Strengthens Commercial Leadership Team with Appointment of Gary Ainsworth as Vice President of Market Access
-
ScaleReady Announces a G-Rex® Grant has been awarded to Seattle Children's Therapeutics
-
Western Exploration Reports Extension of High-grade Mineralization at Gravel Creek
-
Carvana Announces Auction-IRC ‘Megasite’ Integration in Atlanta Area
-
SynergenX Health and HerKare Empower Women with Testosterone Replacement Therapy
-
enBio Corp Launches Transformative Division to Change Biomedical Staffing Nationwide
-
PureTech to Present at 43rd Annual J.P. Morgan Healthcare Conference
-
Bruker Launches Infrared Imaging Microscope for Pharma and Life Science Research
-
Zetagen Therapeutics Expands IP Portfolio, Achieving a Milestone of 64 Worldwide Patents in 2024
-
InMode to Report Fourth Quarter & Full Year 2024 Financial Results and Hold Conference Call on February 6, 2025, Expects Q4 Revenue Between $97.0M-$97.5M
-
Standard BioTools SomaScan Assay Powers Key Insights into Semaglutide Treatment Published in Nature Medicine
-
BioConnect Launches the Arc Series: Biometric Devices for Zero Trust Authentication
-
Lumata Health Announces New Clinical Advisory Board to Advance Efforts in Preventing Blindness through Industry-Leading Intelligent Eye Care Management Platform
-
EVgo Receives First Drawdown from $1.25 Billion Loan Guarantee
-
Otis Fourth Quarter 2024 Earnings Advisory
-
Univar Solutions and dsm-firmenich Unveil Exclusive Distribution Partnership for Innovative Actives Portfolio in Beauty and Personal Care
-
MOMA Therapeutics Provides Corporate Update and Announces Exclusive License Agreement for Selective PARP1 Inhibitor
-
Opthea to Host Investor Days in New York and Australia
-
Black Rifle Coffee Company to Host Investor Event at the 27th Annual ICR Conference
-
Enterprise Declares Quarterly Distribution
-
Mortgage Machine Services Fully Integrates AI-Powered Pricing Engine into Proprietary LOS
-
Butterfly Network Reports Preliminary, Unaudited Fourth Quarter 2024 Revenue Growth of Approximately 35% Year over Year
-
CIChecked™ Continues Great Expansion; Appoints Tyrah Lawson as Senior Director of Operations
-
Viridian Therapeutics Highlights 2025 Corporate Priorities Following Positive Phase 3 Topline Data in Thyroid Eye Disease
-
Heaven's Door Spirits Unveils Bootleg Series Volume VI: Bob Dylan's Repertoire of American Whiskies are the Perfect Blend of Art and Craft
-
MDaudit Announces Strategic Growth Investment from Bregal Sagemount and Primus Capital
-
Marengo's First-in-Class Invikafusp Alfa (STAR0602) Receives U.S. FDA Fast Track Designation for Treatment of Unresectable, Locally Advanced, or Metastatic Colorectal Cancers with High Tumor Mutationa
-
Enanta Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
-
Biomarker and Trial Optimisation Needed to Drive R&D Progress in Alzheimer’s and Related Disorders – ICON Survey
-
Canagold Identifies Significant Antimony Production Potential at New Polaris
-
KARL STORZ Acquires Medical Business of Visual Collaboration Software Company T1V
-
Health Enterprise Partners Announces 2025 RISE Above Award and Names Inaugural Recipient
-
Atea Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
-
United Natural Foods Announces Realignment of Wholesale Business
-
Bigleaf Networks Rebrands Platform as 'Bigleaf Cloud Connect' to Signal New Era of Simplified, Reliable Connectivity
-
Ceva Powers Oritek's Next-Gen ADAS chipsets for Smarter, Safer Electric Vehicles
